Who we partner with
RauMed is selective. We work with healthcare AI companies that meet at least two of three criteria:
- Regulatory traction — FDA, CE/MDR, or clear pathway within 12 months.
- Clinical evidence — publications, RWE, or strong investigator-led studies.
- Strategic relevance — addresses high-volume Turkish clinical needs.
Partnership models
We are flexible on structure. Common arrangements include:
- Exclusive Türkiye distributor.
- Joint venture or co-marketing.
- Pilot-only engagements — IRB-ready clinical validation studies.
- Equity participation — case-by-case, for the right early-stage fit.